Key facts
- ThermoTraumaPort’s last known valuation is $2.7M (May 2025).
- It has raised $580K; the latest was Later Stage VC ($580K) in May 2025.
- Notable investors include Anglia Capital Group, Oxford Technology Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ThermoTraumaPort
- ·The full record, as it builds
Funding rounds
No funding rounds for ThermoTraumaPort are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ThermoTraumaPort
Developer of a patented emergency patient transfer device designed to improve the management of trauma and critically ill patients during their transfer. The company offers a compact, easy-to-use platform with features like active warming, thick foam padding, and single-use covers, enabling healthcare professionals to reduce manual handling, enhance patient comfort, and minimize infection risks, providing a safer and more efficient transfer experience.
- Sector
- Healthcare
- HQ
- Middlessex, United Kingdom
- Founded
- 2014
- Employees
- 5
- Website
- thermotraumaport.com/
- Ownership
- Privately Held (backing)
ThermoTraumaPort doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ThermoTraumaPort shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ThermoTraumaPort in its N-PORT filings yet. We sweep new filings monthly.